Jeni Matsunaga

Our donor program is primarily allogeneic, but we process a few autologous donors every month. The autologous donors are not deferred by cancer as long as they meet the general requirements for donation. For allogeneic donors, our Medical Director updated the cancer deferral guidelines a few years ago: Melanoma: 10 years following removal and completeion of treatment with no reoccurrence Solid Organ Tumors: 5 years following removal and completion of treatment with no reoccurrence (includes Breast, Prostate, Lung, Colon, Ovary) Lymphoma: Permanent deferral Leukemia and other hematopoietic cancers: Permanent deferral

We perform a full antibody identification and get a patient history of recent Rhogam administration. It is reported as "Anti-D, probably due to Rhogam administration on (date of shot)."

Could I please get a copy of that as well? Does this forum have an area for forms sharing? Thanks! Jeni

We have a transfusion audit in place, but I would be interested in seeing both of your audits. Thanks!

Thanks for the welcome!

Hi! A co-worker mentioned Blood Bank Talk, and I look forward to the discussions and exchange of ideas. I work as the Transfusion Service Senior Technologist in a medium-sized hospital in Springfield, MA.